Please login to the form below

Not currently logged in
Email:
Password:

Dihon

This page shows the latest Dihon news and features for those working in and with pharma, biotech and healthcare.

Bayer puts research at heart of business growth

Bayer puts research at heart of business growth

This area has been boosted over the past year with the acquisition of Merck &Co's consumer health division and the takeover of China-based Dihon Pharmaceutical.

Latest news

  • Bayer completes takeover of Chinese OTC company Bayer completes takeover of Chinese OTC company

    The company reported revenues of 123m for 2013 with sales mainly coming in Dihon's home market of China. ... Dihon also has a reach in some emerging markets in Asia and Africa, including NIgera, Vietnam and Cambodia.

  • Pharma is turning its attention to consumer healthcare Pharma is turning its attention to consumer healthcare

    The company also bought Chinese based Dihon Pharmaceuticals, which specialises in OTC medicines and traditional herbal remedies, to increase its offering and presence in Asia.

  • Bayer raises sales predictions for new pharma products Bayer raises sales predictions for new pharma products

    Fresh from announcing a deal to buy Chinese over-the-counter drugmaker Dihon Pharmaceutical, Bayer also reported a 4 per cent sales decline for its consumer health division to 1.96bn - ... Consumer health should return to low- to mid-single-digit growth

  • Bayer buys Chinese consumer care company Bayer buys Chinese consumer care company

    Acquires Dihon Pharmaceutical as Algeta takeover closes.  . Bayer has boosted its consumer healthcare operations in emerging markets with a deal to acquire China-based Dihon Pharmaceutical Group. ... According to its website, Dihon employs more than 2,

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • Sustainable solutions Sustainable solutions

    This was followed five months later by the smaller, but still notable, deal to acquire the Chinese consumer healthcare company Dihon Pharmaceutical for around $485m.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...

Infographics